[1]Patent:US6350764,2002,B2.Locationinpatent:Pagecolumn86
5815-63-4 | N'-Hydroxy-2-(morpholin-4-yl)ethanimidamide | AA00EDVQ | MFCD09948347
62971-64-6 | 3,4-Dimethyl-5-sulfamoylbenzoic acid | AA00EE04 | MFCD07362140
610275-03-1 | 1-(3-Methylbutyl)-1h-benzimidazole-2-carbaldehyde | AA00EE41 | MFCD03130242
5753-50-4 | 2-[(2-Aminoethyl)(methyl)amino]ethanol | AA00EE89 | MFCD10686600
63698-53-3 | 5-(3,4,5-Trimethoxyphenyl)-1,3,4-oxadiazol-2-ol | AA00EEBY | MFCD04582334
56976-66-0 | 5,5-DIPHENYLHYDANTOIN-3-BUTYRIC ACID | AA00EEHO | MFCD00036886
581076-69-9 | N-Acetyl-S-(2,4-dimethylbenzene)-L-cysteine | AA00EENV | MFCD23160313
59574-65-1 | 2-(but-3-en-1-yloxy)oxane | AA00EEV4 | MFCD10568682
58698-37-6 | 2-C-Methyl-D-erythritol | AA00EF18 | MFCD17215928
62133-77-1 | 1,2,3,4-Tetra-O-acetyl-β-D-glucuronic Acid | AA00EF75 | MFCD09841309